CSL - Current Assets


CSL reported $11.85B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Arca Biopharma USD 884.56M 489.31M Jun/2026
aTyr Pharma USD 58.36M 9.21M Jun/2026
Bio Path USD 677K 14K Mar/2026
Brainstorm Cell Therapeutics USD 316K 132K Jun/2026
Cara Therapeutics USD 25.33M 6.21M Mar/2026
CSL USD 11.85B 1000K Dec/2025
Curis USD 16.61M 9.7M Mar/2026
Immunic USD 188.76M 165.89M Mar/2026
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
TherapeuticsMD USD 11.82M 303K Jun/2024